Gevarra, Jaycob B.
HRN: 23-72-50 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/12/2025
MUPIROCIN 2%, 15G (TUBE)
06/12/2025
06/18/2025
TOPICALLY
15g
BID
Skin Lesion
Checking Initial Appropriateness
06/12/2025
FLUCONAZOLE 50MG (CAP)
06/12/2025
06/18/2025
ORAL
25mg
2x/week
T/c Fungal Infection
Checking Initial Appropriateness
06/12/2025
SODIUM FUSIDATE 20MG/G, 15G OINTMENT
06/12/2025
06/18/2025
TOPICAL
20mg
BID
Skin Lesion
Checking Initial Appropriateness
06/16/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/16/2025
06/23/2025
IV
250mg
Q6H
PCAP C
Checking Initial Appropriateness